Organophosphorus hydrolase as an in vivo catalytic nerve agent bioscavenger

Drug Testing and Analysis

Volumn 4, Issue 3-4, 2012, Pages 271-281

  Wales, Melinda E ^a   Reeves, Tony E ^b  

^a TEXAS A AND M UNIVERSITY   (United States)

^b SOUTHWEST RESEARCH INSTITUTE   (United States)

Author keywords

Bioscavenger; In vivo protection; OPH, chemical warfare agents; Organophosphorus hydrolase

Indexed keywords

CHEMICAL WARFARE; HYDROLASES;

BIOSCAVENGER; CATALYTIC EFFICIENCIES; CHEMICAL WARFARE AGENTS; IMMUNOGENICITY; IN VIVO PROTECTION; IN-VIVO; NERVE AGENTS; ORGANOPHOSPHORUS HYDROLASE, CHEMICAL WARFARE AGENT; ORGANOPHOSPHORUS-HYDROLASE;

EFFICIENCY;

ANTIDOTE; ARYLDIALKYLPHOSPHATASE; ATROPINE; ORGANOPHOSPHORUS ACID ANHYDROLASE; ORGANOPHOSPHORUS COMPOUND; PARAOXON; PRALIDOXIME; PYRIDOSTIGMINE; UNCLASSIFIED DRUG;

ALLOPATHY; ANTIOXIDANT ACTIVITY; CATALYSIS; DRUG ELIMINATION; DRUG FORMULATION; DRUG HALF LIFE; DRUG MECHANISM; ENZYME ACTIVITY; HUMAN; IN VIVO STUDY; INTOXICATION; NONHUMAN; ORGANOPHOSPHORUS INTOXICATION; PHARMACOLOGICAL PARAMETERS; PRIORITY JOURNAL; REVIEW; THERAPY EFFECT; VASCULAR RESISTANCE;

EID: 84859420563     PISSN: 19427603     EISSN: 19427611     Source Type: Journal    
DOI: 10.1002/dta.381     Document Type: Review

References (120)

1. A. Chatonnet, O. Lockridge Comparison of butyrylcholinesterase and acetylcholinesterase. Biochem. J. 1989, 260, 625.
2. S. Darvesh, D. A. Hopkins, C. Geula Neurobiology of butyrylcholinesterase. Nat. Rev. Neurosci. 2003, 4, 131.
3. I. Silman, J. L. Sussman Acetylcholinesterase: 'classical' and 'non-classical' functions and pharmacology. Curr. Opin. Pharmacol. 2005, 5, 293.
4. H. Soreq, S. Seidman Acetylcholinesterase - new roles for an old actor. Nat. Rev. Neurosci. 2001, 2, 294.
5. B. J. Gallo, N. J. Lawryk, in Handbook of Pesticide Toxicology, (Eds: W. J. Hayes, E. R. Laws ), Academic Press: San Diego, CA, 1991, pp. 917-983.
6. T. C. Marrs, in Chemical Warfare Agents: Toxicology and Treatment, (Eds: T. C. Marrs, R. L. Maynard, F. R. Sidell ), John Wiley & Sons Ltd: Chichester, UK, 1996, pp. 191.
7. R. L. Maynard, F. W. Beswick, in Clinical and Experimental Toxicology of Organophosphates and Carbamates, (Eds: B. Ballantyne, T. C. Marrs ), Butterworth-Heineman: Oxford, 1992, pp. 373.
8. S. E. Czerwinski, J. P. Skvorak, D. M. Maxwell, D. E. Lenz, S. I. Baskin Effect of octanol:water partition coefficients of OP compounds on biodistribution and percutaneous toxicity. J. Biochem. Mol. Toxic. 2006, 20, 241.
9. J. Bajgar, A. Jakl, V. Hrdina Influence of trimedoxime and atropine on acetylcholinesterase activity in some parts of brain of mice poisoned by isopropylmethyl phosphonofluoridate. Biochem. Pharmacol. 1971, 20, 3230.
10. P. F. Heffron, F. Hobbiger Relationship between inhibition of acetylcholinesterase and response of the rat phrenic nerve-diaphragm preparation to indirect stimulation at higher frequencies. Brit. J. Pharmacol. 1979, 66, 323.
11. P. E. Chabrier, J. Jacob In vivo and in vitro inhibition of cholinesterase by methyl-1 (S-methyl phosphoryl-3) imidazolium (mspi), a model of an instantly aged phosphorylated enzyme. Arch. Toxicol. 1980, 45, 15.
12. C. A. de Candole, W. W. Douglas, C. L. Evans, R. Holmes, K. E. V. Spencer, R. W. Torrance, K. M. Wilson The failure of respiration in death by anticholinesterase poisoning. Br. J. Pharmacol. Chemother. 1953, 6, 466.
13. W. C. Stewart The effects of sarin and atropine on the respiratory center of neuromuscular junctions of the rat. Can. J. Biochem. 1959, 37, 651.
14. R. W. Brimblecombe Drugs acting on central cholinergic mechanisms and affecting respiration. Pharmacol. Therapeut. B 1977, 3, 65.
15. I. B. Wilson, S. Ginsburg A powerful reactivator of alkylphosphate-inhibited acetylcholine-esterase. Biochim. Biophys. Acta 1955, 18, 168.
16. D. E. Lorke, H. Kalasz, G. A. Petroianu, K. Tekes Entry of oximes into the brain: a review. Curr. Med. Chem. 2008, 15, 743.
17. F. Worek, H. Thiermann, L. Szinicz, P. Eyer Kinetic analysis of interactions between human acetylcholinesterase, structurally different organophosphorus compounds and oximes. Biochem. Pharmacol. 2004, 68, 2237.
18. J. H. Fleisher, L. W. Harris Dealkylation as a mechanism for aging of cholinesterase after poisoning with pinacolyl methylphosphonofluoridate. Biochem. Pharmacol. 1965, 14, 641.
19. L. W. Harris, W. C. Heyl, D. L. Stitcher, C. A. Broomfield Effects of 1, 1-oxydimethylene-bis-(4-tert-butyl pyridinium chloride ) (SAD-128) and decamethonium on reactivation of soman- and sarin-inhibited cholinesterase by oximes. Biochem. Pharmacol. 1978, 27, 757.
20. L. W. Harris, J. H. Fleisher, J. Clark, W. J. Cliff Dealkylation and loss of capacity for reactivation of cholinesterase inhibited by sarin. Science 1966, 154, 404.
21. F. R. Sidell, W. A. Groff The reactivatibility of cholinesterase inhibited by VX and sarin in man. Toxicol. Appl. Pharmacol. 1974, 27, 241.
22. M. A. Dunn, B. E. Hackley, F. R. Sidell, in Medical Aspects of Chemical and Biological Warfare. (Eds: F. R. Sidell, E. T. Takafuji, D. R. Franz ), Office of the Surgeon General, Walter Reed Army Medical Center: Washington, DC, 1987, pp. 181.
23. J. J. Gordon, L. Leadbeater, M. P. Maidment Protection of animals against organophosphate poisoning by pretreatment with a carbamate. Toxicol. Appl. Pharmacol. 1978, 43, 207.
24. L. Leadbeater, R. H. Inns, J. M. Rylands Treatment of poisoning by soman. Fund. Appl. Toxicol. 1985, 5, S225.
25. B. G. Talbot, D. R. Anderson, L. W. Harris, L. W. Yarbrough, W. J. Lennox A comparison of in vivo and in vitro rates of aging of soman-inhibited erythrocyte acetylcholinesterase in different animal species. Drug Chem. Toxicol. 1988, 11, 289.
26. A. Saxena, W. Sun, J. M. Fedorko, I. Koplovitz, B. P. Doctor Prophylaxis with human serum butyrylcholinesterase protects guinea pigs exposed to multiple lethal doses of soman or VX. Biochem. Pharmacol. 2011, 81, 164.
27. P. Masson Evolution of and perspectives on therapeutic approaches to nerve agent poisoning. Toxicol. Lett. 2011, 206, 5.
28. J. A. Romano, B. J. Luckey, H. Salem, Chemical Warfare Agents: Chemistry, Pharmacology, Toxicology, and Therapeutics. CRC Press, Boca Raton, FL, 2008.
29. R. C. Gupta, Handbook of Toxicology of Chemical Warfare Agents, Academic Press/Elsevier, Amsterdam, 2009.
30. D. E. Lenz, D. Yeung, J. R. Smith, R. E. Sweeney, L. A. Lumney, D. M. Cerasoli Stoichiometric and catalytic scavengers as protection against nerve agent toxicity: a mini review. Toxicology 2007, 233, 31.
31. P. Masson, D. Rochu Catalytic bioscavengers against toxic esters, an alternative approach for prophylaxis and treatments of poisonings. Acta Naturae 2009, 1, 68.
32. S. B. Bird, A. Dawson, D. Ollis Enzymes and bioscavengers for prophylaxis and treatment of organophosphates poisoning. Front. Biosci. (Schol. Ed.) 2010, 2, 209.
33. P. Masson, F. Nachon, C. A. Broomfield, D. E. Lenz, L. Verdier, L. M. Schopfer, O. Lockridge A collaborative endeavour to design cholinesterase-based catalytic scavengers against toxic organophosphorus esters. Chem. Biol. Interact. 2008, 175, 273.
34. P. Masson, O. Lockridge Butyrylcholinesterase for protection from organophosphorus poisons: catalytic complexity and hysteretic behavior. Arch. Biochem. Biophys. 2010, 494, 107.
35. M. Harel, I. Schalk, L. Ehret-Sabatier, F. Bouet, M. Goeldner, C. Hirth, P. H. Axelsen, I. Silman, J. L. Sussman Quaternary ligand binding to aromatic residues in the active-site gorge of acetylcholinesterase. Proc. Natl Acad. Sci. USA 1993, 90, 9031.
36. C. B. Millard, C. A. Broomfield A computer model of glycosylated human butyrylcholinesterase. Biochem. Biophys. Res. Co. 1992, 189, 1280.
37. C. B. Millard, O. Lockridge, C. A. Broomfield Organophosphorus acid anhydride hydrolase activity in human butyrylcholinesterase-synergy results in a somanase. Biochemistry 1998, 37, 237.
38. B. C. Geyer, L. Kannan, P. E. Garnaud, et al. Plant-derived human butyrylcholinesterase, but not an organophosphorous-compound hydrolyzing variant thereof, protects rodents against nerve agents. Proc. Natl Acad. Sci. USA 2010, 107, 20251.
39. A. C. Hemmert, T. C. Otto, R. A. Chica, et al. Nerve agent hydrolysis activity designed into a human drug metabolism enzyme. PLoS One 2011, 6, e17441.
40. A. R. Main The role of A-esterase in the acute toxicity of paraoxon, tepp, and parathion. Can. J. Biochem. Physiol. 1956, 34, 197.
41. D. E. Lenz, A. A. Brimfield, L. A. Cook, in Development and Applications of Immunoassays for Environmental Analysis, (Eds: D. Aga, E. M. Thurman ), ACS Books: Washington, DC, 1997, pp. 77.
42. D. W. Hanke, M. A. Overton Phosphylation kinetic constants and oxime-induced reactivation in acetylcholinesterase from fetal bovine serum, bovine caudate nucleus, and electric eel. J. Toxicol. Env. Health 1991, 34, 141.
43. J. P. Langenberg, C. VanDijk, R. E. Sweeney, D. M. Maxwell, L. P. A. de Jong, H. P. Benschop Development of a physiologically based model for the toxicokinetics of C(+/-)P(+/-)-soman in the atropinized guinea pig. Arch. Toxicol. 1997, 71, 320.
44. D. Rochu, E. Chabrière, P. Masson Human paraoxonase: a promising approach for pre-treatment and therapy of organophosphorus poisoning. Toxicology 2007, 233, 47.
45. D. T. Yeung, J. R. Smith, R. E. Sweeney, D. E. Lenz, D. E. Cerasoli A gas chromatographic-mass spectrometric approach to examining stereoselective interaction of human plasma proteins with soman. J. Anal. Toxicol. 2008, 32, 86.
46. M. Valiyaveettil, Y. Alamneh, L. Biggemann, I. Soojhawon, B. P. Doctor, M. P. Nambiar Efficient hydrolysis of the chemical warfare nerve agent tabun by recombinant and purified human and rabbit serum paraoxonase 1. Biochem. Biophys. Res. Co. 2010, 403, 97.
47. M. Valiyaveettil, Y. Alamneh, P. Rezk, L. Biggemann, M. Perkins, A. M. Sciuto, B. P. Doctor, M. P. Nambiar Protective efficacy of catalytic bioscavenger, paraoxonase 1 against sarin and soman exposure in guinea pigs. Biochem. Pharmacol. 2011, 81, 800.
48. S. Z. Fairchild, M. W. Peterson, A. Hamza, C. G. Zhan, D. M. Cerasoli, W. E. Chang Computational characterization of how the VX nerve agent binds to human serum paraoxonase 1. J. Mol. Model. 2011, 17, 97.
49. D. T. Yeung, D. E. Lenz, D. M. Cerasoli Analysis of active-site amino-acid residues of human serum paraoxonase using competitive substrates. FEBS J. 2005, 272, 2225.
50. P. Masson, D. Josse, O. Lockridge, N. Viguie, C. TaupC. Buhler Enzymes hydrolyzing organophosphates as potential catalytic scavengers against organophosphate poisoning. J. Physiology Paris 1998, 92, 357.
51. M. Harel, A. Aharoni, L. Gaidukov, et al. Structure and evolution of the serum paraoxonase family of detoxifying and antiatherosclerotic enzymes. Nat. Struct. Mol. Biol. 2004, 11, 412.
52. R. D. Gupta, M. Goldsmith, Y. Ashani, et al. Directed evolution of hydrolases for prevention of G-type nerve agent intoxication. Nat. Chem. Biol. 2011, 510, 120.
53. A. Aharoni, L. Gaidukov, S. Yagur, L. Toker, I. Silman, D. S. Tawfik Directed evolution of mammalian paraoxonases PON1 and PON3 for bacterial expression and catalytic specialization. P. Natl Acad. Sci. USA 2004, 101, 487.
54. T. C. Otto, C. K. Harsch, D. T. Yeung, T. J. Magliery, D. M. Cerasoli, D. E. Lenz Dramatic differences in organophosphorus hydrolase activity between human and chimeric recombinant mammalian paraoxonase-1 enzymes. Biochemistry 2009, 48, 10416.
55. R. C. Stevens, S. M. Suzuki, T. B. Cole, S. S. Oark, R. J. Richter, C. E. Furlong Engineered recombinant human paraoxonase 1 (rHuPON1) purified from Escherichia coli protects against organophosphate poisoning. Proc. Natl Acad. Sci. USA 2008, 105, 12780.
56. T. C. Otto, S. A. Kasten, E. Kovaleva, Z. Liu, G. Buchman, M. Tolosa, D. Davis, J. R. Smith, R. Belcerzak, D. E. Lenz, D. M. Cerasoli Purification and characterization of functional human paraoxonase-1 expressed in Trichoplusia ni larvae. Chem. Biol. Interact. 2010, 187, 388.
57. E. G. Duysen, K. Parikh, V. Aleti, V. Manne, O. Lockridge, N. Chilukuri Adenovirus-mediated human paraoxonase1 gene transfer to provide protection against the toxicity of the organophosphorus pesticide toxicant diazoxon. Gene Ther. 2011, 18, 250.
58. K. Parikh, E. G. Duysen, B. Snow, N. S. Jensen, V. Manne, O. Lockridge, N. Chilukuri Gene-delivery butyrylcholinesterase is prophylactic against the toxicity of chemical warfare nerve agents and organophosphorus compounds. J. Pharmacol. Exp. Ther. 2011, 337, 92.
59. F. C. Hoskin Diisopropylphosphorofluoridate and tabun: enzymatic hydrolysis and nerve function. Science 1971, 172, 1243.
60. E. I. Scharff, J. Koepke, G. Fritzsch, C. Lücke, H. Rüterjans Crystal structure of diisopropylfluorophosphatase from Loligo vulgaris. Structure 2001, 9, 493.
61. E. I. Scharff, C. Lücke, G. Fritzsch, J. Koepke, J. Hartleib, S. Dierl, H. Rüterjans Crystallization and preliminary X-ray crystallographic analysis of DFPase from Loligo vulgaris. Acta Crystallogr. D 2001, 57, 148.
62. M. Melzer, J. C.-H. Chen, A. Heidenreich, J. Gäb, M. Koller, K. Kehe, M.-M. Blum Reversed enantioselectivity of diisopropyl fluorophosphatase against organophosphorus nerve agents by rational design. J. Am. Chem. Soc. 2009, 131, 17226.
63. J. Hartleib, H. Rüterjans High-yield expression, purification, and characterization of the recombinant diisopropylfluorophosphatase from Loligo vulgaris. Protein Expr. Purif. 2001, 21, 210.
64. B. K. Singh, A. Walker Microbial degradation of organophosphorus compounds. FEMS Microbiol. Rev. 2006, 30, 428.
65. R. S. Gold, M. E. Wales, J. K. Grimsley, J. R. Wild, in Enzymes in Action, (Ed: B. Zwanenburg ) Kluwar Academic Publishers: the Netherlands, 2000, pp. 263-286.
66. C. M. Seibert, F. M. Raushel Structural and catalytic diversity within the amidohydrolase superfamily. Biochemistry 2005, 44, 6383.
67. L. Afriat, C. Roodveldt, G. Manco, D. S. Tawfik The latent promiscuity of newly identified microbial lactonases is linked to a recently diverged phosphotriesterase. Biochemistry 2006, 45, 13677.
68. W. W. Mulbry, J. S. Karns, P. C. Kearney, J. O. Nelson, C. S. McDaniel, J. R. Wild Identification of a plasmid-borne parathion hydrolase gene from Flavobacterium sp. by southern hybridization with opd from Pseudomonas diminuta. Appl. Environ. Microb. 1986, 51, 926.
69. C. S. McDaniel, L. L. Harper, J. R. Wild Cloning and sequencing of a plasmid-borne gene (opd) encoding a phosphotriesterase. J. Bacteriol. 1988, 170, 2306.
70. C. M. Serdar, D. T. Gibson Enzymatic hydrolysis of organophosphates: cloning and expression of a parathion hydrolase gene from Pseudomonas diminuta. Biotechnology 1985, 3, 567.
71. C. M. Serdar, D. T. Gibson, D. M. Munnecke, J. H. Lancaster Plasmid involvement in parathion hydrolysis by Pseudomonas diminuta. Appl. Environ. Microbiol. 1982, 44, 246.
72. I. Horne, T. D. Sutherland, R. L. Harcourt, R. J. Russell, J. G. Oakeshott Identification of an opd (organophosphate degradation) gene in an Agrobacterium Isolate. Appl. Environ. Microbiol. 2002, 68, 3371.
73. B. diSioudi, C. E. Miller, K. Lai, J. K. Grimsley, J. R. Wild Rational design of organophosphorus hydrolase for altered substrate specificities. Chem. Biol. Interact. 1999, 119, 211.
74. J. E. Kolakowski, J. J. DeFrank, S. P. Harvey, L. L. Szafraniec, W. T. Beaudry, K. H. Lai, J. R. Wild Enzymatic hydrolysis of the chemical warfare agent VX and its neurotoxic analogues by organophosphorus hydrolase. Biocatal. Biotransfor. 1997, 15, 297.
75. V. K. Rastogi, J. J. DeFrank, T.-C. Chen, J. R. Wild Enzymatic hydrolysis of Russian-VX by organophosphorus hydrolase. Biochem. Biophys. Res. Co. 1997, 241, 294.
76. D. P. Dumas, H. D. Durst, W. G. Landis, F. M. Raushel, J. R. Wild Inactivation of organophosphorus nerve agents by the phosphotriesterase from Pseudomonas diminuta. Arch. Biochem. Biophys. 1990, 277, 155.
77. L. Raveh, Y. Segall, H. Leader, N. Rothschild, D. Levanon, Y. Henis, Y. Ashani Protection against tabun toxicity in mice by prophylaxis with an enzyme hydrolyzing organophosphate esters. Biochem. Pharmacol. 1992, 44, 397.
78. C. Roodveldt, D. S. Tawfik Shared promiscuous activities and evolutionary features in various members of the amidohydrolase superfamily. Biochemistry 2005, 44, 12728.
79. J. J. DeFrank, W. T. Beaudry, T.-C., S. P. Harvey, A. N. Stroup, L. L. Szafraniec Screening of halophilic bacteria and Alteromonas species for organophosphorus hydrolyzing enzyme activity. Chem. Biol. Interact. 1993, 87, 141.
80. T.-C. Cheng, L. Liu, B. Wang, J. Wu, J. J. DeFrank, D. M. Anderson, V. K. Rastogi, A. B. Hamilton Nucleotide sequence of a gene encoding an organophosphorus nerve agent degrading enzyme from Alteromonas haloplanktis. J. Ind. Microbiol. Biotech. 1997, 18, 49.
81. T.-C. Cheng, S. P. Harvey, G. L. Chen Cloning and expression of a gene encoding a bacterial enzyme for decontamination of organophosphorus nerve agents and nucleotide sequence of the enzyme. Appl. Environ. Microbiol. 1996, 62, 1636.
82. M. J. Maher, M. Ghosh, A. M. Grunden, A. L. Menon, M. W. Adams, H. C. Freeman, J. M. Guss Structure of the prolidase from Pyrococcus furiosus. Biochemistry 2004, 43, 2771.
83. S. L. Roderick, B. W. Matthews Structure of the cobalt dependent methionine aminopeptidase from Escherichia coli: A new type of proteolytic enzyme. Biochemistry 1993, 32, 3907.
84. N. K. Vyas, A. Nickitenko, V. K. Rastogi, S. S. Shah, F. A. Quiocho Structural insights into the dual activities of the nerve agent degrading organophosphate anhydrolase/prolidase. Biochemistry 2010, 49, 547.
85. T.-C. Cheng, S. P. Harvey, A. N. Stroup Purification and properties of a highly active organophosphorus acid anhydrolase from Alteromonas undina. Appl. Environ. Microbiol. 1993, 59, 3138.
86. C. M. Hill, F. Wu, T.-C. Cheng, J. J. DeFrank, F. M. Raushel Substrate and stereochemical specificity of the organophosphorus acid anhydrolase from Alteromonas sp. JD6.5 toward p-nitrophenyl phosphotriesters. Bioorg. Med. Chem. Lett. 2000, 10, 1285.
87. C. L. Zhongli, L. Shunpeng, F. Guoping Isolation of methyl parathion-degrading strain M6 and cloning of the methyl parathion hydrolase gene. Appl. Environ. Microbiol. 2001, 67, 4922.
88. Y.-J. Dong, M. Bartlam, L. Sun, Y.-F. Zhou, Z.-P. Zhang, C.-G. Zhang, Z. Rao, X.-E. Zhang Crystal structure of methyl parathion hydrolase from Pseudomonas sp. WBC-3. J. Mol. Biol. 2005, 353, 655.
89. O. Khersonsky, C. Roodveldt, D. S. Tawfik Enzyme promiscuity: evolutionary and mechanistic aspects. Curr. Opin. Chem. Biol. 2006, 10, 498.
90. L. Mandrich, L. Merone, G. Manco Hyperthermophilic phosphotriesterases/lactonases for the environment and human health. Environ. Technol. 2010, 31, 1115.
91. D. F. Xiang, P. Kolb, A. A. Fedorov, M. Meier, L. V. Fedorov, T. T. Nguyen, R. Sterner, S. C. Almo, B. K. Shoichet, F. M. Raushel Functional annotation and three-dimensional structure of Dr0930 from Deinococcus radiodurans, a close relative of phosphotriesterase in the amidohydrolase superfamily. Biochemistry 2009, 48, 2237.
92. Y. Ashani, N. Rothschild, Y. Segall, D. Levanon, L. Raveh Prophylaxis against organophosphate poisoning by an enzyme hydrolyzing organophosphorus compounds in mice. Life Sci. 1991, 49, 367.
93. C. A. Broomfield A purified recombinant organophosphorus acid anhydrase protects mice against soman. Chem. Biol. Interact. 1993, 87, 279.
94. K. Tuovinen, E. Kaliste-Korhonen, F. M. Raushel, O. Hanninen, Phosphotriesterase-a promising candidate for use in detoxification of organophosphates. Fund. Appl. Toxicol. 1994, 23, 578.
95. I. Petrikovics, M. E. Wales, J. C. Jaszberenyi, M. Budai, S. I. BaskM. Szilasi, B. A. Logue, P. Chapela, J. R. Wild Enzyme-based intravascular defense against organophosphorus neurotoxins: synergism of dendritic-enzyme complexes with 2-PAM and atropine. Nanotoxicology 2007, 1, 85.
96. C. Gresham, C. Rosenbaum, R. J. Gaspari, C. J. Jackson, S. B. Bird Kinetics and efficacy of an organophosphorus hydrolase in a rodent model of methyl parathion poisoning. Acad. Emerg. Med. 2010, 17, 736.
97. T. E. Reeves, M. E. Wales, J. K. Grimsley, P. Li, D. M. Cerasoli, J. R. Wild Balancing the stability and the catalytic specificities of OP hydrolases with enhanced V-agent activities. Protein Eng. Des. Sel. 2008, 21, 405.
98. E. Carletti, L. Jacquamet, M. Loiodice, D. Rochu, P. Masson, F. Nachon Update on biochemical properties of recombinant Pseudomonas diminuta phosphotriesterase. J. Enzyme Inhib. Med. Chem. 2009, 24, 1045.
99. D. Rochu, N. Viguie, F. Renault, D. Crouzier, M. T. Froment, P. Masson Contribution of the active-site metal cation to the catalytic activity and to the conformational stability of phosphotriesterase: temperature- and pH dependence. Biochem. J. 2004, 380, 627.
100. C. Roodveldt, D. S. Tawfik Directed evolution of phosphotriesterase from Pseudomonas diminuta for heterologous expression in Escherichia coli results in stabilization of the metal-free state. Protein Eng. Des. Sel. 2005, 18, 58.
101. O. Tenberken, H. Thiermann, F. Worek, G. Reiter Chromatographic preparation and kinetic analysis of interactions between tabun enantiomers and acetylcholinesterase. Toxicol. Lett. 2010, 195, 142.
102. M. J. van der Schans, B. J. Lander, H. van der Wiel, J. P. Langenberg, H. P. Benschop Toxicokinetics of the nerve agent (+/-)-VX in anesthetized and atropinized hairless guinea pigs and marmosets after intravenous and percutaneous administration. Toxicol. Appl. Pharmacol. 2003, 191, 48.
103. H. P. Benschop, C. A. Konings, J. van Genderen, L. P. de Jong Isolation, anticholinesterase properties, and acute toxicity in mice of the four stereoisomers of the nerve agent soman. Toxicol. Appl. Pharmacol. 1984, 72, 61.
104. A. H. Due, H. C. Trap, J. P. Langenberg, H. P. Benschop Toxicokinetics of soman stereoisomers after subcutaneous administration to atropinized guinea pigs. Arch. Toxicol. 1994, 68, 60.
105. C. M. Hill, W.-S. Li, J. B. Thoden, H. M. Holden, F. M. Raushel Enhanced degradation of chemical warfare agents through molecular engineering of the phosphotriesterase active site. J. Am. Chem. Soc. 2003, 125, 8990.
106. M. Chen-Goodspeed, M. A. Sogorb, F. Wu, F. M. Raushel Enhancement, relaxation, and reversal of the stereoselectivity for phosphotriesterase by rational evolution of active site residues. Biochemistry 2001, 40, 1332.
107. B. N. Novikov, J. K. Grimsley, R. J. Kern, J. R. Wild, M. E. Wales Improved pharmacokinetics and immunogenicity profile of organophosphorus hydrolase by chemical modification with polyethylene glycol. J. Control. Release 2010, 146, 318.
108. M. Trovaslet-Leroya, L. Musilova, F. Renault, et al. Organophosphate hydrolases as catalytic bioscavengers of organophosphorus nerve agents. Toxicol. Lett. 2011, 206, 14.
109. L. Pei, I. Petrikovics, J. L. Way Antagonism of the lethal effects of paraoxon by carrier erythrocytes containing phosphotriesterase. Fund. Appl. Toxicol. 1995, 28, 209.
110. L. Pei, G. Omburo, W. D. McGuinn, I. Petrikovics, K. Dave, F. M. Raushel, J. R. Wild, J. R. DeLoach, J. L. Way Encapsulation of phosphotriesterase within murine erythrocytes. Toxicol. Appl. Pharma. 1994, 124, 296.
111. R. M. Fielding, D. D. Lasic Liposomes in the treatment of infectious diseases. Expert Opin. Ther. Pat. 1999, 9, 1679.
112. I. Petrikovics, K. Hong, G. Omburo, Q. Z. Hu, L. Pei, W. D. McGuinn, D. Sylvester, C. Tamulinas, D. Papahadjopoulos, J. C. Jaszberenyi, J. L. Way Antagonism of paraoxon intoxication by recombinant phosphotriesterase encapsulated within sterically stabilized liposomes. Toxicol. Appl. Pharmacol. 1999, 156, 56.
113. I. Petrikovics, W. D. McGuinn, D. Sylvester, P. Yuzapavik, J. Jiang, J. L. Way, D. Papahadjopoulos, K. Hong, R. YT.-C. Cheng, J. J. DeFrank In vitro studies on sterically stabilized liposomes (SL) as enzyme carriers in organophosphorus (OP) antagonism. Drug Deliv. 2000, 7, 83.
114. I. Petrikovics, T.-C. Cheng, D. Papahadjopoulos, et al. Long circulating liposomes encapsulating organophosphorus acid anhydrolase in diisopropylfluorophosphate antagonism. Toxicol. Sci. 2000, 57, 16.
115. I. Petrikovics, D. Papahadjopoulos, K. Hong, T.-C. Cheng, S. I. BaskJ. Jiang, J. C. Jaszberenyi, B. A. Logue, M. Szilasi, W. D. McGuinn, J. L. Way Comparing therapeutic and prophylactic protection against the lethal effect of paraoxon. Toxicol. Sci. 2004, 77, 258.
116. R. Webster, E. Didier, P. Harris, N. Siegel, J. Stadler, L. Tilbury, D. Smith, PEGylated proteins: evaluation of their safety in the absence of definitive metabolism studies. Drug Metab. Dispos. 2007, 35, 9.
117. Q. An, Y. Lei, N. Jia, et al. Effect of site-directed PEGylation of trichosanthin on its biological activity, immunogenicity, and pharmacokinetics. Biomol. Eng. 2007, 24, 643.
118. A. J. Chirino, M. L. Ary, S. A. Marshall Minimizing the immunogenicity of protein therapeutics. Drug Discov. Today 2004, 9, 82.
119. A. Smolen, H. W. Eckerson, K. N. Gan, N. Hailat, B. N. La Du Characteristics of the genetically determined allozymic forms of human serum paraoxonase/arylesterase. Drug Metab. Dispos. 1991, 19, 107.
120. B. D. diSioudi, J. K. Grimsley, K. Lai, J. R. Wild Modification of near active site residues in organophosphorus hydrolase reduces metal stoichiometry and alters substrate specificity. Biochemistry 1999, 38, 2866.